AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,054,000 | +64.2% | 665,764 | +15.7% | 0.01% | +50.0% |
| Q4 2018 | $5,514,000 | -61.0% | 575,587 | -50.8% | 0.00% | -20.0% |
| Q3 2018 | $14,144,000 | +61.5% | 1,169,932 | +108.6% | 0.01% | -16.7% |
| Q2 2018 | $8,759,000 | +4.3% | 560,777 | +0.5% | 0.01% | 0.0% |
| Q1 2018 | $8,394,000 | +10.1% | 558,083 | +5.4% | 0.01% | +20.0% |
| Q4 2017 | $7,622,000 | -8.1% | 529,668 | -3.7% | 0.01% | -16.7% |
| Q3 2017 | $8,297,000 | +68.9% | 550,188 | +12.8% | 0.01% | +100.0% |
| Q2 2017 | $4,912,000 | +58.1% | 487,751 | +12.0% | 0.00% | +50.0% |
| Q1 2017 | $3,106,000 | +53.1% | 435,615 | +6.7% | 0.00% | 0.0% |
| Q4 2016 | $2,029,000 | -34.8% | 408,172 | -3.0% | 0.00% | 0.0% |
| Q3 2016 | $3,114,000 | +45.3% | 420,836 | +7.2% | 0.00% | 0.0% |
| Q2 2016 | $2,143,000 | -28.2% | 392,451 | +11.2% | 0.00% | 0.0% |
| Q1 2016 | $2,983,000 | -14.1% | 353,065 | -1.4% | 0.00% | -33.3% |
| Q4 2015 | $3,472,000 | -32.4% | 357,920 | -2.5% | 0.00% | -25.0% |
| Q3 2015 | $5,138,000 | +10.4% | 367,284 | +11.7% | 0.00% | +33.3% |
| Q2 2015 | $4,652,000 | +1717.2% | 328,777 | +166.3% | 0.00% | – |
| Q1 2014 | $256,000 | -11.7% | 123,481 | 0.0% | 0.00% | – |
| Q4 2013 | $290,000 | +1.4% | 123,481 | 0.0% | 0.00% | – |
| Q3 2013 | $286,000 | +3.6% | 123,481 | +4.3% | 0.00% | – |
| Q2 2013 | $276,000 | – | 118,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |